Pharmaceutics 2011, 3(2), 186-228; doi:10.3390/pharmaceutics3020186

Design, Synthesis, and Biological Evaluation of PKD Inhibitors

1, 1, 1, 2, 2, 2, 2,3, 2,3, 2 and 1,* email
Received: 17 February 2011; in revised form: 1 April 2011 / Accepted: 19 April 2011 / Published: 21 April 2011
(This article belongs to the Special Issue Drug Discovery Tools)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Protein kinase D (PKD) belongs to a family of serine/threonine kinases that play an important role in basic cellular processes and are implicated in the pathogenesis of several diseases. Progress in our understanding of the biological functions of PKD has been limited due to the lack of a PKD-specific inhibitor. The benzoxoloazepinolone CID755673 was recently reported as the first potent and kinase-selective inhibitor for this enzyme. For structure-activity analysis purposes, a series of analogs was prepared and their in vitro inhibitory potency evaluated.
Keywords: protein kinase D; small molecule inhibitor; benzothienothiazepinone; pyrimidines; CID755673; thiazepinothiophenopyrimidinone
PDF Full-text Download PDF Full-Text [1040 KB, uploaded 21 April 2011 11:03 CEST]

Export to BibTeX |

MDPI and ACS Style

George, K.M.; Frantz, M.-C.; Bravo-Altamirano, K.; LaValle, C.R.; Tandon, M.; Leimgruber, S.; Sharlow, E.R.; Lazo, J.S.; Wang, Q.J.; Wipf, P. Design, Synthesis, and Biological Evaluation of PKD Inhibitors. Pharmaceutics 2011, 3, 186-228.

AMA Style

George KM, Frantz M-C, Bravo-Altamirano K, LaValle CR, Tandon M, Leimgruber S, Sharlow ER, Lazo JS, Wang QJ, Wipf P. Design, Synthesis, and Biological Evaluation of PKD Inhibitors. Pharmaceutics. 2011; 3(2):186-228.

Chicago/Turabian Style

George, Kara M.; Frantz, Marie-Céline; Bravo-Altamirano, Karla; LaValle, Courtney R.; Tandon, Manuj; Leimgruber, Stephanie; Sharlow, Elizabeth R.; Lazo, John S.; Wang, Q. Jane; Wipf, Peter. 2011. "Design, Synthesis, and Biological Evaluation of PKD Inhibitors." Pharmaceutics 3, no. 2: 186-228.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert